3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
2
TP53 Y220C Mutation
1
Smoking
1
Rectal Neoplasms
1
Pulmonary Disease, Chronic Obstructive
1
Peripheral Nervous System Diseases
1
Meningioma
1
Medulloblastoma
1
Lymphoma, Mantle-Cell
1
Localized Prostate Cancer
1
Leukemia, Myeloid, Acute
1
Head and Neck Neoplasms
1
HER2 IHC3+ Advanced Colorectal Cancer
1
Genetic Diseases, Inborn
1
Deglutition Disorders
1
Cognitive Dysfunction
1
Interventions
Cyclophosphamide
15
venetoclax
11
fludarabine
10
Cytarabine
10
Mycophenolic Acid
6
Azacitidine
6
fludarabine phosphate
5
Daunorubicin
5
Busulfan
5
ruxolitinib
4
ponatinib
4
blinatumomab
4
Whole-Body Irradiation
4
Vincristine
4
Tacrolimus
4
Rituximab
4
Methotrexate
4
Dexamethasone
4
asciminib
3
Mercaptopurine
3
Inotuzumab Ozogamicin
3
Granulocyte Colony-Stimulating Factor
3
Cyclosporine
3
revumenib
2
quizartinib
2
pegaspargase
2
nilotinib
2
ibrutinib
2
Thioguanine
2
Prednisone
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Leukemia
×
Tablets
×
90 days
×
Clear all
No trials found.